Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 16 studies | 37% ± 14% | |
classical monocyte | 8 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of GPBAR1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 96% | 379.99 | 346 / 359 | 85% | 4.84 | 242 / 286 |
intestine | 97% | 262.98 | 933 / 966 | 73% | 2.59 | 386 / 527 |
bladder | 100% | 334.05 | 21 / 21 | 49% | 1.46 | 249 / 504 |
pancreas | 46% | 51.94 | 151 / 328 | 94% | 10.76 | 168 / 178 |
ovary | 76% | 119.99 | 136 / 180 | 58% | 1.27 | 249 / 430 |
lung | 86% | 153.41 | 496 / 578 | 41% | 1.48 | 472 / 1155 |
breast | 92% | 1114.26 | 420 / 459 | 29% | 0.52 | 325 / 1118 |
adrenal gland | 69% | 94.38 | 178 / 258 | 37% | 1.32 | 86 / 230 |
esophagus | 55% | 103.83 | 796 / 1445 | 47% | 1.32 | 86 / 183 |
adipose | 100% | 1633.27 | 1199 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 499.27 | 238 / 241 | 0% | 0 | 0 / 0 |
kidney | 45% | 118.70 | 40 / 89 | 53% | 1.20 | 478 / 901 |
thymus | 73% | 117.12 | 477 / 653 | 24% | 0.39 | 144 / 605 |
liver | 42% | 53.58 | 95 / 226 | 52% | 2.08 | 213 / 406 |
prostate | 57% | 71.30 | 140 / 245 | 27% | 0.44 | 136 / 502 |
peripheral blood | 80% | 711.45 | 742 / 929 | 0% | 0 | 0 / 0 |
heart | 79% | 164.15 | 684 / 861 | 0% | 0 | 0 / 0 |
uterus | 45% | 43.61 | 76 / 170 | 32% | 0.86 | 146 / 459 |
skin | 35% | 51.15 | 625 / 1809 | 39% | 0.88 | 183 / 472 |
blood vessel | 50% | 132.18 | 666 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 1.43 | 14 / 29 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.46 | 12 / 45 |
eye | 0% | 0 | 0 / 0 | 19% | 0.37 | 15 / 80 |
brain | 0% | 0.77 | 9 / 2642 | 13% | 0.21 | 95 / 705 |
muscle | 7% | 6.56 | 56 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0038184 | Biological process | adenylate cyclase-activating G protein-coupled bile acid receptor signaling pathway |
GO_1903413 | Biological process | cellular response to bile acid |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_2000810 | Biological process | regulation of bicellular tight junction assembly |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_1904056 | Biological process | positive regulation of cholangiocyte proliferation |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0038182 | Molecular function | G protein-coupled bile acid receptor activity |
Gene name | GPBAR1 |
Protein name | G-protein coupled bile acid receptor 1 (G-protein coupled receptor GPCR19) (hGPCR19) (Membrane-type receptor for bile acids) (M-BAR) (hBG37) (BG37) |
Synonyms | TGR5 |
Description | FUNCTION: Receptor for bile acid. Bile acid-binding induces its internalization, activation of extracellular signal-regulated kinase and intracellular cAMP production. May be involved in the suppression of macrophage functions by bile acids. . |
Accessions | ENST00000479077.5 ENST00000522678.5 ENST00000521462.1 Q8TDU6 ENST00000519574.2 |